Literature DB >> 17304377

Colon cancer presenting as Streptococcus gallolyticus infective endocarditis.

H Kok1, R Jureen, C Y Soon, B H Tey.   

Abstract

A 58-year-old Chinese man presented with a three-week history of fever. He had a background history of rheumatic heart disease, hypertension, and thalassaemia. He was found to have infective endocarditis of the aortic valve due to Streptococcus gallolyticus. During the hospital stay, he developed a few episodes of haematochaezia and was subsequently found to have colonic carcinomain- situ. He completed appropriate antibiotic treatment for his infective endocarditis and underwent a left hemicolectomy with primary anastomosis. The association between Streptococcus gallolyticus infective endocarditis and colonic neoplasm is well documented. This case report stresses the importance of performing routine colonoscopy to look for colonic neoplastic change in patients diagnosed to have Streptococcus gallolyticus infective endocarditis. The early diagnosis of the colonic neoplasm has enabled our patient to have a curative surgery without compromising his quality of life.

Entities:  

Mesh:

Year:  2007        PMID: 17304377

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  11 in total

1.  Species-Specific Identification of Streptococcus based on DNA Marker in 16S-23S rDNA Internal Transcribed Spacer.

Authors:  Jia Yu; Ting Zhou; Baojie Zhu; Yuxi Wei; Xuerui Li; Yin Liu
Journal:  Curr Microbiol       Date:  2020-04-06       Impact factor: 2.188

2.  Competence for natural genetic transformation in the Streptococcus bovis group streptococci S. infantarius and S. macedonicus.

Authors:  Donald A Morrison; Eric Guédon; Pierre Renault
Journal:  J Bacteriol       Date:  2013-03-29       Impact factor: 3.490

Review 3.  Bacterial oncogenesis in the colon.

Authors:  Christine Dejea; Elizabeth Wick; Cynthia L Sears
Journal:  Future Microbiol       Date:  2013-04       Impact factor: 3.165

4.  Identification of clinically relevant nonhemolytic Streptococci on the basis of sequence analysis of 16S-23S intergenic spacer region and partial gdh gene.

Authors:  Xiaohui Chen Nielsen; Ulrik Stenz Justesen; Rimtas Dargis; Michael Kemp; Jens Jørgen Christensen
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

5.  Correlation among Streptococcus bovis, endocarditis and septicemia in a patient with advanced colon cancer: a case report.

Authors:  Chiara Abeni; Luigina Rota; Chiara Ogliosi; Paola Bertocchi; Pietro Berra Centurini; Alberto Zaniboni
Journal:  J Med Case Rep       Date:  2013-07-15

Review 6.  The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role.

Authors:  Ahmed S Abdulamir; Rand R Hafidh; Fatimah Abu Bakar
Journal:  J Exp Clin Cancer Res       Date:  2011-01-20

Review 7.  Significance of Streptococcus gallolyticus subsp. gallolyticus Association With Colorectal Cancer.

Authors:  Ewa Pasquereau-Kotula; Mariana Martins; Laetitia Aymeric; Shaynoor Dramsi
Journal:  Front Microbiol       Date:  2018-04-03       Impact factor: 5.640

8.  Increased Intracellular Cyclic di-AMP Levels Sensitize Streptococcus gallolyticus subsp. gallolyticus to Osmotic Stress and Reduce Biofilm Formation and Adherence on Intestinal Cells.

Authors:  Wooi Keong Teh; Shaynoor Dramsi; Tim Tolker-Nielsen; Liang Yang; Michael Givskov
Journal:  J Bacteriol       Date:  2019-02-25       Impact factor: 3.490

9.  Significance of infectious agents in colorectal cancer development.

Authors:  Vlado Antonic; Alexander Stojadinovic; Kent E Kester; Peter J Weina; Björn Ldm Brücher; Mladjan Protic; Itzhak Avital; Mina Izadjoo
Journal:  J Cancer       Date:  2013-03-15       Impact factor: 4.207

10.  Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned. Case report.

Authors:  Alberta Ferrari; Ivan Botrugno; Elisa Bombelli; Tommaso Dominioni; Emma Cavazzi; Paolo Dionigi
Journal:  World J Surg Oncol       Date:  2008-05-12       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.